|
Clinical Discussion Group
Join Keith Flaherty, MD and David McDermott, MD for a clinical update on novel agents and therapeutic strategies in the treatment of Metastatic
Melanoma.
|
 |
Novel Agents for the Treatment of Metastatic Melanoma
David F. McDermott, MD
Beth Israel Deaconess Medical Center
Topics include:
- Targeted therapy
- B-Raf inhibition
- Apoptosis induction
- Novel targets
|
|
 |
Future Directions: Opportunities for Targeting B-RAF and Other Targets in Melanoma Management
Keith T. Flaherty, MD
Abramson Cancer Center of the University of Pennsylvania
Topics include:
- Novel cytotoxics
- Signal transduction inhibitors
- Anti-angiogenic & novel immunotherapies
|
Available until March 2009, this activity offers:
Physicians: 1 AMA PRA Category 1 Credit™
Nurses: 1 contact hour
Pharmacists: 1 contact hour (0.1 CEU)
This series is made possible by educational grants from Bayer HeathCare Pharmaceuticals and Onyx Pharmaceuticals.
[Back to top]
[Back to Activity Home]
|
